For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
Anti-PD-1 in Cancer Therapy: Understanding Response and Resistance
Tea will be served at 3:45 pm.
This program is open to the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
New York, NY 10065
Molecular Pharmacology and Chemical Biology Programs
Suzanne Topalian, MD
Professor of Surgery and Oncology
Director, Melanoma Program
Associate Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine